Adicet Bio (ACET)
(Delayed Data from NSDQ)
$1.51 USD
0.00 (0.00%)
Updated Aug 1, 2024 04:00 PM ET
After-Market: $1.52 +0.01 (0.66%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Adicet Bio, Inc. [ACET]
Reports for Purchase
Showing records 41 - 60 ( 108 total )
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
4Q22 Results; Plans for FDA Meeting in 2Q23 Regarding Potential Pivotal Study for ADI-001
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Q4 Financials; ADI-001 Development to Mature in 2023
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
HCW 2023 Top Picks: Seize the Opportunities
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Positive Updated ADI-001 Data at ASH; Pivotal Study Could Begin in 2Q23; Raise PT by $4
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
ADI-001 Ph 1 Data Update; Post-CAR-T Setting Near Term Opportunity
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
SITC 2022 Conference Roundup for Covered Companies
Provider: Wedbush Securities Inc.
Analyst: Research Department
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Q3 Financials; ADI-001 Update at ASH; R&D Day Recap
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Q3 Financials; ADI-001 Update At ASH; R&D Day Recap
Provider: Wedbush Securities Inc.
Analyst: Research Department
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
3Q22 Results; Updated ADI-001 Data at ASH; R&D Webcast Event on November 10, 2022
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
ASH 2022 Abstract Roundup for Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Updated Data For Phase 1 Trial of ADI-001 in NHL Included in ASH Abstract
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology - Relevant Abstracts at SITC 2022
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
Company: Adicet Bio, Inc.
Industry: Medical - Biomedical and Genetics
2Q22 Results; Additional Phase 1 ADI-001 NHL Clinical Update Expected in 2H22
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E